Archives: 2020-02-29

In Situ Printing of Adhesive Hydrogel Scaffolds for the Treatment of Skeletal Muscle Injuries

Biomedical engineers at the UConn School of Dental Medicine recently developed a handheld 3D bioprinter that could revolutionize the way musculoskeletal surgical procedures are performed. The bioprinter, developed by Dr. Ali Tamayol, associate professor in the School of Dental Medicine biomedical engineering department, enables surgeons to deposit scaffolds–or materials to help support cellular and tissue

Read More

COVID-19 a Reminder of the Challenge of Emerging Infectious Diseases. A new paper of NIH scientists published on NEJM

The emergence and rapid increase in cases of coronavirus disease 2019 (COVID-19), a respiratory illness caused by a novel coronavirus, pose complex challenges to the global public health, research and medical communities, write federal scientists from NIH’s National Institute of Allergy and Infectious Diseases (NIAID) and from the Centers for Disease Control and Prevention (CDC).

Read More

WHO has increased assessment of the COVID-19 risk of spread and impact from high to very high at a global level.

WHO Director-General’s opening remarks at the media briefing on COVID-19 – 28 February 2020 In the past 24 hours, China reported 329 cases – the lowest in more than a month. As of 6am Geneva time this morning, China has reported a total of 78,959 cases of COVID-19 to WHO, including 2791 deaths. Outside China,

Read More

Scientists of Case Western Reserve University successfully test new way to deliver gene therapy

Researchers use lipids to safely deliver gene therapy to the eye, successfully holding off advance of rare, inherited eye disorder Researchers at Case Western Reserve University have used a unique method to safely deliver gene therapy to fight a rare, but irreversible, genetic eye disorder known as Stargardt disease.  By using chemically modified lipids—instead of the

Read More

Gene therapy generates new neurons to treat Huntington’s disease

Gene therapy to treat Huntington’s disease Huntington’s disease (HD) is a rare disease characterized by abnormal chorea movement and caused by Huntingtin (Htt) gene mutation and neurodegeneration in a brain area called striatum. A research group led by Dr. Gong Chen, a former professor at Penn State University and now leading a brain repair center

Read More

New Report from ARM Provides Overview of the Regenerative Medicine Landscape for Rare Disease

Rare Disease & Regenerative Medicine 2019 This report provides industry specific statistics compiled from cell therapy, gene therapy, tissue engineering, and other regenerative medicine companies active in developing therapies for rare disease and provides context for the potential of regenerative medicine to improve upon the current standard of care.